Wednesday, September 16, 2026Latest filing Sep 14, 2026

Nicole Malliotakis Periodic Transaction Report

Filed Jan 7, 2025 · House Clerk · 3 transactions

U.S. Representative · R · NY-11 · All trades by Nicole Malliotakis

On January 7, 2025, Rep. Nicole Malliotakis (R-NY-11) filed a periodic transaction report with the House Clerk disclosing 3 transactions (2 purchases, 1 sale) dated Dec 24, 2024.

The filing covers 1 ticker, including $BA.

Reported amount ranges sum to $116K–$315K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 14 days.

Source document: House Clerk filing 8220710

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Nicole Malliotakis · Bought · Dec 24 · $100K–$250K

0.52MED
Disclosure speedx 0.250.60
Trade sizex 0.250.75
Cluster activityx 0.150.00
Track recordx 0.350.52

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Nicole Malliotakis

Get an email the moment Nicole Malliotakis files the next one. Free, no card, no spam.

Follow free →
3
Transactions
2 / 1
Buys / sells
1
Tickers
14d
Longest lag

Tickers in this filing

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
Dec 24, 2024BABoeing (Boeing Common Stock)buy$1K–$15K14d
Dec 24, 2024US Treasury Billsell$15K–$50K14d
Dec 24, 2024US Treasury Billbuy$100K–$250K14d

Other recent filings by Nicole Malliotakis

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →